This is a regulatory disclosure made by Max Healthcare Institute Limited (the Company) under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It provides an update on ongoing litigation.
The disclosure is a continuation of a previous intimation dated May 19, 2026, regarding litigation against Kalinga Hospital Ltd. (KHL), a subsidiary of the Company. The litigation, filed under sections 241 and 242 of the Companies Act, 2013, also involves other shareholders of KHL from whom the Company acquired its majority equity stake.
A new development is the filing of an interlocutory petition before the Hon'ble National Company Law Tribunal (NCLT), Cuttack Bench. The petition was filed by the legal representatives of BRS Capital Two Pte. Limited. The petition requests a stay on the Postal Ballot Notice dated May 29, 2026, which was issued by KHL. The purpose of this Postal Ballot was to seek approval for increasing borrowing limits and creating a charge on the assets of the Company.
The petitions were listed for a hearing before the NCLT on July 7, 2026, at 11:30 am IST.
As per the enclosed annexure detailing the requirements of Regulation 30:
- The NCLT, Cuttack Bench heard the submissions of the parties for the petitions, including the new interlocutory petition.
- The tribunal adjourned the matters to July 23, 2026, for further hearing.
- Details regarding litigation against key management personnel or a settlement of proceedings are noted as not applicable.
The financial impact of the ongoing litigation and the interlocutory petition is not quantified in this disclosure.
The disclosure was signed by Dhiraj Aroraa, EVP - Company Secretary and Compliance Officer, and will be hosted on the Company's website (www.maxhealthcare.in).